Cargando…

Heart Transplantation in Congenital Heart Disease: In Whom to Consider and When?

Due to impressive improvements in surgical repair options, even patients with complex congenital heart disease (CHD) may survive into adulthood and have a high risk of end-stage heart failure. Thus, the number of patients with CHD needing heart transplantation (HTx) has been increasing in the last d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Attenhofer Jost, Christine H., Schmidt, Dörthe, Huebler, Michael, Balmer, Christian, Noll, Georg, Caduff, Rosmarie, Greutmann, Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3614026/ https://www.ncbi.nlm.nih.gov/pubmed/23577237 http://dx.doi.org/10.1155/2013/376027

Ejemplares similares

Association of cerebellar volume with cognitive and motor function in adults with congenital heart disease
por: Naef, Nadja, et al.
Publicado: (2023)

Heart Transplantation in Congenital Heart Disease
por: Parisi, Francesco
Publicado: (2011)

PSA screening – for whom and when?
por: Albers, Peter
Publicado: (2019)

Bempedoic Acid: for Whom and When
por: Ruscica, Massimiliano, et al.
Publicado: (2022)

Medical Treatment of Aortic Aneurysms in Marfan Syndrome and other Heritable Conditions
por: Jost, Christine H. Attenhofer, et al.
Publicado: (2014)

The impact of trisomy 21 on treatment modalities and outcome in adults with congenital heart disease in Switzerland
por: Johannes, Judith, et al.
Publicado: (2018)

Altered white matter microstructure is related to cognition in adults with congenital heart disease
por: Ehrler, Melanie, et al.
Publicado: (2020)

Computer aided planning of patches and conduits for surgery in congenital heart disease
por: Riesenkampff, Eugenié, et al.
Publicado: (2011)

Cardiomyopathy Induced by Artificial Cardiac Pacing: To Whom, When, Why, and How? Insights on Heart Failure Development
por: Ferrari, Andres Di Leoni, et al.
Publicado: (2023)

Brain volumes in adults with congenital heart disease correlate with executive function abilities
por: Naef, Nadja, et al.
Publicado: (2021)

Indications for Heart Transplantation in Congenital Heart Disease
por: Siân Pincott, E, et al.
Publicado: (2011)

Checkpoint and PARP inhibitors, for whom and when
por: Lee, Jung-Min, et al.
Publicado: (2017)

Freeze-all, for whom, when, and how
por: Celada, Paula, et al.
Publicado: (2020)

Immunologic Considerations in Heart Transplantation for Congenital Heart Disease
por: Kaufman, Beth D, et al.
Publicado: (2011)

To Whom It May Concern: Patents Considered in Relation to the Patentees and the Public
Publicado: (1889)

Cytokine removal: do not ban it, but learn in whom and when to use it
por: Schmidt, Bernhard M. W., et al.
Publicado: (2023)

Microstructural alterations of the corticospinal tract are associated with poor motor function in patients with severe congenital heart disease
por: Ehrler, Melanie, et al.
Publicado: (2021)

Commentary: Toward mechanical circulatory support in univentricular hearts
por: Huebler, Michael, et al.
Publicado: (2021)

Oncoplastic Breast Surgery: What, When and for Whom?
por: Macmillan, R. Douglas, et al.
Publicado: (2016)

COVID-19 patients: when and whom to ventilate?
por: Lal, Tusharindra, et al.
Publicado: (2020)

Radiotherapy in Pancreatic Cancer: To Whom, When, and How?
por: Falco, Michał, et al.
Publicado: (2023)

Heart Transplantation for Congenital Heart Disease in the First Year of Life
por: Chinnock, Richard E, et al.
Publicado: (2011)

Anesthetic Management for Heart Transplantation in Adults with Congenital Heart Disease
por: Yuki, Koichi
Publicado: (2020)

Quality of Life After Heart Transplantation for Congenital Heart Defect
por: Martens, Sabrina, et al.
Publicado: (2022)

Collaterals in congenital heart disease: when and how to treat?
por: Van De Bruaene, Alexander, et al.
Publicado: (2023)

Non-invasive ventilation in the ED: Whom, When, How?
por: Göksu, Erkan, et al.
Publicado: (2018)

Salvage radiotherapy with or without hormone therapy: for whom and when?
por: Carrie, Christian
Publicado: (2017)

Laparoscopy in Blunt Abdominal Trauma: for Whom? When?and Why?
por: Justin, Viktor, et al.
Publicado: (2017)

To immunosuppress: whom, when and how? That is the question with COVID-19
por: Winthrop, Kevin L, et al.
Publicado: (2020)

Severe Asthma and Biological Therapy: When, Which, and for Whom
por: Rogliani, Paola, et al.
Publicado: (2019)

In search of the optimal proteosome inhibitor. How, when and for whom?
por: Engelhardt, Monika, et al.
Publicado: (2021)

Capsule Endoscopy in Inflammatory Bowel Disease: When? To Whom?
por: Na, Soo-Young, et al.
Publicado: (2021)

Genetic testing in focal segmental glomerulosclerosis: in whom and when?
por: Tato, Ana María, et al.
Publicado: (2023)

Impact of Pulmonary Vascular Resistances in Heart Transplantation for Congenital Heart Disease
por: Gazit, Avihu Z, et al.
Publicado: (2011)

Heart Transplantation in Biventricular Congenital Heart Disease: Indications, Techniques, and Outcomes
por: Mora, Bassem N, et al.
Publicado: (2011)

Outcome following heart transplant assessment in adults with congenital heart disease
por: Crossland, David Steven, et al.
Publicado: (2019)

Heart transplantation surgery in children and young adults with congenital heart disease
por: Martens, Sabrina, et al.
Publicado: (2023)

When to consider lung transplantation for COVID-19
por: Cypel, Marcelo, et al.
Publicado: (2020)

A case report: pause and consider the late complications of heart transplantation
por: Sinha, Tejas, et al.
Publicado: (2019)

The Kinetics of Anti-HLA Antibodies in the First Year after Kidney Transplantation: In Whom and When Should They Be Monitored?
por: de Castro, Maria Cristina Ribeiro, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bcv7gnv9j6uuc3fcjfel86uv4h